Adrah Levin

1.6k total citations
17 papers, 1.2k citations indexed

About

Adrah Levin is a scholar working on Epidemiology, Infectious Diseases and Small Animals. According to data from OpenAlex, Adrah Levin has authored 17 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 10 papers in Infectious Diseases and 8 papers in Small Animals. Recurrent topics in Adrah Levin's work include Mycobacterium research and diagnosis (14 papers), Tuberculosis Research and Epidemiology (10 papers) and Infectious Diseases and Mycology (8 papers). Adrah Levin is often cited by papers focused on Mycobacterium research and diagnosis (14 papers), Tuberculosis Research and Epidemiology (10 papers) and Infectious Diseases and Mycology (8 papers). Adrah Levin collaborates with scholars based in United States, Netherlands and Canada. Adrah Levin's co-authors include Charles L. Daley, Gwen A. Huitt, Julie Jarand, John D. Mitchell, Lening Zhang, Scott D. Sagel, Stacey L. Martiniano, Jerry A. Nick, Leonid Heifets and Sarah Elizabeth Totten and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Clinical Infectious Diseases and Clinical Cancer Research.

In The Last Decade

Adrah Levin

17 papers receiving 1.2k citations

Peers

Adrah Levin
Adrah Levin
Citations per year, relative to Adrah Levin Adrah Levin (= 1×) peers Shanti Natarajan‐Amé

Countries citing papers authored by Adrah Levin

Since Specialization
Citations

This map shows the geographic impact of Adrah Levin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrah Levin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrah Levin more than expected).

Fields of papers citing papers by Adrah Levin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrah Levin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrah Levin. The network helps show where Adrah Levin may publish in the future.

Co-authorship network of co-authors of Adrah Levin

This figure shows the co-authorship network connecting the top 25 collaborators of Adrah Levin. A scholar is included among the top collaborators of Adrah Levin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrah Levin. Adrah Levin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bullington, Wendy, Adrah Levin, Cara D Varley, et al.. (2023). Long-term Safety and Tolerability of Omadacycline for the Treatment of Mycobacterium abscessus Infections. Open Forum Infectious Diseases. 10(7). ofad335–ofad335. 24 indexed citations
2.
Davidson, Rebecca M., Nabeeh A. Hasan, L. Elaine Epperson, et al.. (2021). Population Genomics of Mycobacterium abscessus from U.S. Cystic Fibrosis Care Centers. Annals of the American Thoracic Society. 18(12). 1960–1969. 43 indexed citations
3.
Hasan, Nabeeh A., Rebecca M. Davidson, L. Elaine Epperson, et al.. (2021). Population Genomics and Inference of Mycobacterium avium Complex Clusters in Cystic Fibrosis Care Centers, United States. Emerging infectious diseases. 27(11). 2836–2846. 24 indexed citations
4.
Kwon, Yong Soo, Adrah Levin, Shannon Kasperbauer, Gwen A. Huitt, & Charles L. Daley. (2019). Efficacy and safety of tigecycline for Mycobacterium abscessus disease. Respiratory Medicine. 158. 89–91. 23 indexed citations
5.
Julian, Kathleen G., Catharine I. Paules, Barbara Hasse, et al.. (2019). Long-term follow-up of post-cardiac surgery Mycobacterium chimaera infections: A 5-center case series. Journal of Infection. 80(2). 197–203. 7 indexed citations
6.
Martiniano, Stacey L., Brandie D. Wagner, Adrah Levin, et al.. (2017). Safety and Effectiveness of Clofazimine for Primary and Refractory Nontuberculous Mycobacterial Infection. CHEST Journal. 152(4). 800–809. 103 indexed citations
7.
Czaja, Christopher A., Adrah Levin, Christian W. Cox, et al.. (2015). Improvement in Quality of Life after Therapy for Mycobacterium abscessus Group Lung Infection. A Prospective Cohort Study. Annals of the American Thoracic Society. 13(1). 40–48. 41 indexed citations
8.
Davidson, Rebecca M., Nabeeh A. Hasan, Paul R. Reynolds, et al.. (2014). Genome Sequencing of Mycobacterium abscessus Isolates from Patients in the United States and Comparisons to Globally Diverse Clinical Strains. Journal of Clinical Microbiology. 52(10). 3573–3582. 54 indexed citations
9.
Kartalija, Marinka, Alida R. Ovrutsky, Gregory B. Pott, et al.. (2012). Patients with Nontuberculous Mycobacterial Lung Disease Exhibit Unique Body and Immune Phenotypes. American Journal of Respiratory and Critical Care Medicine. 187(2). 197–205. 169 indexed citations
10.
Ingen, Jakko van, Eric F. Egelund, Adrah Levin, et al.. (2012). The Pharmacokinetics and Pharmacodynamics of Pulmonary Mycobacterium avium Complex Disease Treatment. American Journal of Respiratory and Critical Care Medicine. 186(6). 559–565. 146 indexed citations
11.
Kitada, Seigo, Adrah Levin, R.J. Harbeck, et al.. (2012). Serodiagnosis of Mycobacterium avium complex pulmonary disease in the USA. European Respiratory Journal. 42(2). 454–460. 37 indexed citations
12.
Jarand, Julie, Adrah Levin, Lening Zhang, et al.. (2011). Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary Disease. Clinical Infectious Diseases. 52(5). 565–571. 311 indexed citations
13.
Ingen, Jakko van, Adrah Levin, Sarah Elizabeth Totten, et al.. (2011). Pharmacokinetics And Drug Susceptibility Testing Imply Limited Activity Of Current Regimens For Mycobacterium Avium Complex Disease. A2404–A2404. 1 indexed citations
14.
Abou‐Alfa, Ghassan K., Paul B. Chapman, Jonas Feilchenfeldt, et al.. (2010). Targeting Mutated K-ras in Pancreatic Adenocarcinoma Using an Adjuvant Vaccine. American Journal of Clinical Oncology. 34(3). 321–325. 87 indexed citations
15.
Kitada, Seigo, Adrah Levin, Brendan Clark, et al.. (2010). Serodiagnosis Of Mycobacterium Avium Complex Pulmonary Disease In The United States. A2614–A2614. 1 indexed citations
16.
Basche, M., Anna E. Barón, Sabine Eckhardt, et al.. (2008). Barriers to Enrollment of Elderly Adults in Early-Phase Cancer Clinical Trials. Journal of Oncology Practice. 4(4). 162–168. 49 indexed citations
17.
Basche, M., Daniel L. Gustafson, Scott N. Holden, et al.. (2006). A Phase I Biological and Pharmacologic Study of the Heparanase Inhibitor PI-88 in Patients with Advanced Solid Tumors. Clinical Cancer Research. 12(18). 5471–5480. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026